These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Handling false positives in the genomic era. Moyer AM Clin Chem; 2012 Nov; 58(11):1605-6. PubMed ID: 23256212 [No Abstract] [Full Text] [Related]
3. Methods: Face up to false positives. Macarthur D Nature; 2012 Jul; 487(7408):427-8. PubMed ID: 22836983 [No Abstract] [Full Text] [Related]
4. Human genomics in China--ten years endeavor: from planning to implementation. Chen Z; Zhao GP Sci China C Life Sci; 2009 Jan; 52(1):2-6. PubMed ID: 19152078 [No Abstract] [Full Text] [Related]
5. 'Platinum' genome takes on disease. Callaway E Nature; 2014 Nov; 515(7527):323. PubMed ID: 25409806 [No Abstract] [Full Text] [Related]
6. A primer on deep learning in genomics. Zou J; Huss M; Abid A; Mohammadi P; Torkamani A; Telenti A Nat Genet; 2019 Jan; 51(1):12-18. PubMed ID: 30478442 [TBL] [Abstract][Full Text] [Related]
7. Assemblies: the good, the bad, the ugly. Birney E Nat Methods; 2011 Jan; 8(1):59-60. PubMed ID: 21191376 [No Abstract] [Full Text] [Related]
8. Genomics: the personal side of genomics. Blow N Nature; 2007 Oct; 449(7162):627-30. PubMed ID: 17914399 [No Abstract] [Full Text] [Related]
10. Framework for quality assessment of whole genome cancer sequences. Whalley JP; Buchhalter I; Rheinbay E; Raine KM; Stobbe MD; Kleinheinz K; Werner J; Beltran S; Gut M; Hübschmann D; Hutter B; Livitz D; Perry MD; Rosenberg M; Saksena G; Trotta JR; Eils R; Gerhard DS; Campbell PJ; Schlesner M; Gut IG Nat Commun; 2020 Oct; 11(1):5040. PubMed ID: 33028839 [TBL] [Abstract][Full Text] [Related]
11. Standardized nomenclature and open science in Human Genomics. Vasiliou V; Veselkov K; Bruford E; Reichardt JKV Hum Genomics; 2021 Feb; 15(1):13. PubMed ID: 33612096 [No Abstract] [Full Text] [Related]
12. Human genomics: The end of the start for population sequencing. Birney E; Soranzo N Nature; 2015 Oct; 526(7571):52-3. PubMed ID: 26432243 [No Abstract] [Full Text] [Related]
13. What is finished, and why does it matter. Mardis E; McPherson J; Martienssen R; Wilson RK; McCombie WR Genome Res; 2002 May; 12(5):669-71. PubMed ID: 11997333 [No Abstract] [Full Text] [Related]
14. Targeted or whole genome sequencing of formalin fixed tissue samples: potential applications in cancer genomics. Munchel S; Hoang Y; Zhao Y; Cottrell J; Klotzle B; Godwin AK; Koestler D; Beyerlein P; Fan JB; Bibikova M; Chien J Oncotarget; 2015 Sep; 6(28):25943-61. PubMed ID: 26305677 [TBL] [Abstract][Full Text] [Related]
15. Gene centre chips in with better route to microarrays. Abbott A Nature; 2002 Nov; 420(6911):3. PubMed ID: 12422168 [No Abstract] [Full Text] [Related]
16. Competition boosts bid to find human genes. Abbott A Nature; 2005 May; 435(7039):134. PubMed ID: 15889055 [No Abstract] [Full Text] [Related]
17. Project set to map marks on genome. Abbott A Nature; 2010 Feb; 463(7281):596-7. PubMed ID: 20162836 [No Abstract] [Full Text] [Related]
18. Time for a standardized system of reporting sites of genomic methylation. Saffery R; Gordon L Genome Biol; 2015 Apr; 16(1):85. PubMed ID: 25924664 [TBL] [Abstract][Full Text] [Related]
19. Genome builders face the competition. Hayden EC Nature; 2011 Mar; 471(7339):425. PubMed ID: 21430748 [No Abstract] [Full Text] [Related]
20. Assembly of long, error-prone reads using repeat graphs. Kolmogorov M; Yuan J; Lin Y; Pevzner PA Nat Biotechnol; 2019 May; 37(5):540-546. PubMed ID: 30936562 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]